Cargando…
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies
DPP8/9 inhibition induces either pyroptotic or apoptotic cell death in hematological malignancies. We previously reported that treatment with the DPP8/9 inhibitor 1G244 resulted in apoptotic cell death in myeloma, and our current study further evaluates the mechanism of action of 1G244 in different...
Autores principales: | Kikuchi, Shohei, Wada, Akinori, Kamihara, Yusuke, Okazaki, Kosuke, Jawaid, Paras, Rehman, Mati Ur, Kobayashi, Eiji, Susukida, Takeshi, Minemura, Tomoki, Nabe, Yoshimi, Iwao, Noriaki, Ozawa, Tatsuhiko, Hatano, Ryo, Yamada, Mitsugu, Kishi, Hiroyuki, Matsuya, Yuji, Mizuguchi, Mineyuki, Hayakawa, Yoshihiro, Dang, Nam H., Sakamoto, Yasumitsu, Morimoto, Chikao, Sato, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093441/ https://www.ncbi.nlm.nih.gov/pubmed/37048172 http://dx.doi.org/10.3390/cells12071100 |
Ejemplares similares
-
DPP8 is a novel therapeutic target for multiple myeloma
por: Sato, Tsutomu, et al.
Publicado: (2019) -
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies
por: Kobayashi, Eiji, et al.
Publicado: (2023) -
Involvement of activation induced cytidine deaminase in malignant B-cells expressing two distinct M-components as an etiology of biclonal gammopathy
por: Kikuchi, Shohei, et al.
Publicado: (2022) -
Early complete response of primary bone marrow B‐cell lymphoma treated with rituximab‐based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement
por: Nabe, Yoshimi, et al.
Publicado: (2021) -
A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL
por: Kikuchi, Shohei, et al.
Publicado: (2023)